EBIT at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's EBIT?
- Lexicon Pharmaceuticals (LXRX) reported EBIT of -$996K in Q1 2026.
- How has Lexicon Pharmaceuticals's EBIT changed year-over-year?
- Lexicon Pharmaceuticals's EBIT increased by 96.1% year-over-year, from -$25.68M to -$996K.
- What is the long-term trend for Lexicon Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's EBIT has grown at a -13.4% compound annual growth rate (CAGR), from -$87.09M to -$48.91M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.